Product NDC: | 0093-0309 |
Proprietary Name: | Clemastine Fumarate |
Non Proprietary Name: | Clemastine Fumarate |
Active Ingredient(s): | .5 mg/5mL & nbsp; Clemastine Fumarate |
Administration Route(s): | ORAL |
Dosage Form(s): | SYRUP |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0093-0309 |
Labeler Name: | Teva Pharmaceuticals USA Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA073399 |
Marketing Category: | ANDA |
Start Marketing Date: | 19950329 |
Package NDC: | 0093-0309-12 |
Package Description: | 120 mL in 1 BOTTLE (0093-0309-12) |
NDC Code | 0093-0309-12 |
Proprietary Name | Clemastine Fumarate |
Package Description | 120 mL in 1 BOTTLE (0093-0309-12) |
Product NDC | 0093-0309 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Clemastine Fumarate |
Dosage Form Name | SYRUP |
Route Name | ORAL |
Start Marketing Date | 19950329 |
Marketing Category Name | ANDA |
Labeler Name | Teva Pharmaceuticals USA Inc |
Substance Name | CLEMASTINE FUMARATE |
Strength Number | .5 |
Strength Unit | mg/5mL |
Pharmaceutical Classes |